![Lara Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lara Sullivan
No open positions remaining
Net worth: 5 M $ as of 2026-07-30
Profile
Lara S.
Sullivan was the founder of SpringWorks Therapeutics LLC, founded in 2015, serving as President & Director from 2015 to 2018.
Former jobs include President, CEO, Director & Chief Medical Officer at Pyxis Oncology, Inc. from 2025 to 2026; Director at Rexahn Pharmaceuticals, Inc.; Associate Partner at McKinsey & Co., Inc.; VP-Medical, Worldwide Research & Development at Pfizer Inc. from 2011 to 2017; and Principal at Paul Capital Partners (United Kingdom).
Education includes undergraduate degree from Cornell University, doctorate from Perelman School of Medicine, and MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 2.95% | 2026-04-19 | 1,866,547 ( 2.95% ) | 5 M $ | 2026-07-30 |
Former positions of Lara Sullivan
| Companies | Position | End |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Chief Executive Officer | 2026-02-02 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Founder | 2017-12-31 |
| PFIZER INC. | Chief Tech/Sci/R&D Officer | 2017-08-31 |
Paul Capital Partners (United Kingdom)
 Paul Capital Partners (United Kingdom) Investment ManagersFinance Provides investment consulting services | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Training of Lara Sullivan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paul Capital Partners (United Kingdom)
Paul Capital Partners (United Kingdom) Investment ManagersFinance Provides investment consulting services | Finance |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company that develops oncology medicines | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
- Stock Market
- Insiders
- Lara Sullivan
